ERBB2 and breast cancer: Some histologic and immunologic indicators, such as hormone receptor (HR), human epidermal growth factor receptor-2 (HER-2), and Ki-67 of breast cancer, have significant implications in the prognosis and choice of treatment for breast cancer (Ge et al., 2015).